Steve Bryson, PhD, science writer—

Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.

Articles by Steve Bryson

September 8, 2020 News by Steve Bryson, PhD

ST-920 Gene Therapy Found Safe, Effective in Mouse Model; Supports First-In-Human Trial

A single administration of the experimental gene therapy ST-920 in a Fabry disease mouse model safely and effectively increased the levels of the alpha-GalA enzyme — which is lacking in people with the genetic disorder — in…

March 24, 2020 News by Steve Bryson, PhD

FLT190 Granted Orphan Drug Status in Europe as Potential Gene Therapy for Fabry Disease

The gene therapy candidate FLT190 — designed to increase blood levels of the enzyme alpha-GAL A, which is affected in Fabry disease — has been granted orphan drug designation by the European Commission,…

Subscribe to our newsletter

Get regular updates to your inbox.

Steve Bryson, PhD, science writer—

Articles by Steve Bryson

ST-920 Gene Therapy Found Safe, Effective in Mouse Model; Supports First-In-Human Trial

FLT190 Granted Orphan Drug Status in Europe as Potential Gene Therapy for Fabry Disease

Recent Posts

Subscribe to our newsletter